Expertise at Chang Gung System

Cheng, Nai-Ming , M.D.
Intitution:Chang Gung Memorial Hospital, Keelung
Position: Attending Physician
Department: Department of Nuclear Medicine in Keelung Chang Gung Memorial Hospital
Address: No.5, Fusing St., Gueishan Township, Taoyuan County 333, Taiwan (R.O.C.)
Tel:02-24313131 Fax:+886 3 2110052
E-mail: tc99m@adm.cgmh.org.tw

Focus of Interest :
  • Neurosciences
  • Oncology
  • Radiology, Nuclear Medicine

Fulltime Employment:
  1. 2010/07 /01~ Attending Physician , Dept of Nuclear Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
  2. 2006/03/31 - 2010/06/30 Resident physician, Chang Gung Memorial Hospital, Taiwan.

Education:
  • Medical doctor, Tzu Chi University

Selected Main Publications:
  1. Cheng NM, Yu CT, Ho KC, Wu YC, Liu YC, Wang CW, Yen TC. Respiration-Averaged CT for Attenuation Correction in Non-Small-Cell Lung Cancer. Eur J Nucl Med Mol Imaging.2009 Apr;36(4):607-15
  2. Nai-Ming Cheng, Joseph Tung-Chieh Chang, Chung-Guei Huang, Din-Li Tsan, Shu-Hang Ng, Hung-Ming Wang, Chun-Ta Liao, Chien-Yu Lin, Cheng-Lung Hsu, and Tzu-Chen Yen. Prognostic value of pretreatment 18F FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging.2012 Nov;39(11):1673-84
  3. Nai-Ming Cheng, Yu-Hua Dean Fang, Joseph Tung-Chieh Chang, Chung-Guei Huang, Din-Li Tsan, Shu-Hang Ng, Hung-Ming Wang, Chien-Yu Lin, Chun-Ta Liao, and Tzu-Chen Yen. Texture Features of Pretreatment 18F FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-stage Oropharyngeal Squamous Cell Carcinoma. J Nucl Med. 2013 Oct;54(10):1703-9
  4. Nai-Ming Cheng, Yu-Hua Dean Fang and Tzu-Chen Yen. The Promise and Limits of PET Texture Analysis. Ann Nucl Med. 2013 Nov;27(9):867-9
  5. Nai-Ming Cheng, Yu-Hua Dean Fang, Li-Yu Lee, Joseph Tung-Chieh Chang, Din-Li Tsan, Shu-Hang Ng, Hung-Ming Wang, Chun-Ta Liao, Lan-Yan Yang, Ching-Han Hsu and Tzu-Chen Yen*. Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):419-28
Full Publication List

Board Certification:
 1. Member of Society of Nuclear Medicine, Taiwan(R.O.C)

Ongoing projects:
 1. Risk stratification model for oropharyngeal cancer patients: integrating data from FDG PET, immunohistochemistry and clinical factors